Clinical course of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis
- PMID: 32414594
- PMCID: PMC7252193
- DOI: 10.1016/j.jtcvs.2020.04.005
Clinical course of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis
Abstract
Objectives: To illustrate the clinical course and difficulties in early diagnosis of coronavirus disease 2019 (COVID-19) in patients after thoracic surgery.
Methods: We retrospectively analyzed the clinical course of the first 11 patients diagnosed with COVID-19 after thoracic surgery in early January 2020. Postoperative clinical, laboratory, and radiologic records and the time line of clinical course were summarized. Potential prognostic factors were evaluated.
Results: In the 11 confirmed cases (3 female, 8 male), median days from symptom onset to case detection was 8. Insidious symptom onset and misinterpreted postoperative changes on chest computed tomography (CT) resulted in delay in diagnosis. There were 3 fatalities due to respiratory failure, whereas 4 severe and 4 mild cases recovered and were discharged. All patients had once experienced leukocytosis and eosinopenia. Remittent fever and resected lung segments ≥5 were associated with fatality.
Conclusions: The case fatality rate of postsurgical patients subsequently diagnosed with COVID-19 was 27.3%. Insidious symptom onset, postoperative leukocytosis with lymphopenia, and postsurgical CT changes overshadowed the early signs of viral pneumonia. Dynamic symptom monitoring, serial chest CTs, and tests for viral RNA and serum antibody improve the chance for prompt detection of COVID-19. Consideration should be given to preadmission and preoperative screening and strict contact isolation during the postoperative period.
Keywords: COVID-19; Sars-Cov-2; esophageal cancer; lung cancer; postoperative; surgery.
Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Figures




Comment in
-
Commentary: The double responsibility of the thoracic surgeon at the time of the pandemic: A perspective from the North of Italy.J Thorac Cardiovasc Surg. 2020 Aug;160(2):595-596. doi: 10.1016/j.jtcvs.2020.04.003. Epub 2020 Apr 10. J Thorac Cardiovasc Surg. 2020. PMID: 32317105 Free PMC article. No abstract available.
-
Commentary: Challenges to thoracic surgeons in the global coronavirus pandemic.J Thorac Cardiovasc Surg. 2020 Aug;160(2):593-594. doi: 10.1016/j.jtcvs.2020.04.004. Epub 2020 Apr 10. J Thorac Cardiovasc Surg. 2020. PMID: 32331818 Free PMC article. No abstract available.
-
Commentary: Echoes of war.J Thorac Cardiovasc Surg. 2020 Aug;160(2):594-595. doi: 10.1016/j.jtcvs.2020.03.130. Epub 2020 Apr 10. J Thorac Cardiovasc Surg. 2020. PMID: 32448688 Free PMC article. No abstract available.
-
Thoracic surgeons' insights: Improving thoracic surgery outcomes during the Coronavirus Disease 2019 pandemic.Eur J Cardiothorac Surg. 2020 Aug 1;58(2):207-209. doi: 10.1093/ejcts/ezaa214. Eur J Cardiothorac Surg. 2020. PMID: 32496537 Free PMC article. No abstract available.
-
Thoracic surgeons' insights: Improving thoracic surgery outcomes during the Coronavirus Disease 2019 pandemic.J Thorac Cardiovasc Surg. 2020 Aug;160(2):597-600. doi: 10.1016/j.jtcvs.2020.04.038. Epub 2020 Jun 4. J Thorac Cardiovasc Surg. 2020. PMID: 32507690 Free PMC article.
References
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239–1242. - PubMed
-
- Chinese National Health Commission . 2020. Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (7th edition)http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb19... Available at:
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous